Harvest Investment Services LLC purchased a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 2,855 shares of the biotechnology company's stock, valued at approximately $1,697,000.
A number of other large investors also recently made changes to their positions in the business. Asset Dedication LLC raised its stake in shares of Axon Enterprise by 11.3% during the 4th quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company's stock worth $106,000 after purchasing an additional 18 shares in the last quarter. Bleakley Financial Group LLC grew its position in shares of Axon Enterprise by 1.3% in the fourth quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company's stock valued at $908,000 after purchasing an additional 20 shares during the last quarter. Venturi Wealth Management LLC increased its position in Axon Enterprise by 2.7% in the 4th quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company's stock worth $477,000 after buying an additional 21 shares during the period. Burns Matteson Capital Management LLC increased its position in Axon Enterprise by 3.4% during the fourth quarter. Burns Matteson Capital Management LLC now owns 757 shares of the biotechnology company's stock worth $450,000 after acquiring an additional 25 shares during the period. Finally, Transcend Capital Advisors LLC lifted its stake in shares of Axon Enterprise by 3.6% in the fourth quarter. Transcend Capital Advisors LLC now owns 726 shares of the biotechnology company's stock valued at $431,000 after buying an additional 25 shares during the period. Institutional investors and hedge funds own 79.08% of the company's stock.
Axon Enterprise Stock Performance
Shares of AXON stock traded up $13.11 on Friday, reaching $603.78. The stock had a trading volume of 556,214 shares, compared to its average volume of 777,156. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $47.00 billion, a price-to-earnings ratio of 156.02, a P/E/G ratio of 5.17 and a beta of 1.13. The firm's 50-day moving average is $545.51 and its two-hundred day moving average is $571.68.
Analyst Ratings Changes
Several analysts have recently weighed in on AXON shares. The Goldman Sachs Group lifted their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a research report on Monday, January 27th. Needham & Company LLC reissued a "buy" rating and set a $600.00 price objective on shares of Axon Enterprise in a report on Wednesday. Craig Hallum cut Axon Enterprise from a "buy" rating to a "cautious" rating in a research note on Monday, March 10th. TD Cowen assumed coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price objective on the stock. Finally, Northcoast Research lowered Axon Enterprise from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 19th. One analyst has rated the stock with a sell rating, two have given a hold rating and nine have assigned a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $626.45.
View Our Latest Report on AXON
Insider Buying and Selling
In related news, CEO Patrick W. Smith sold 10,000 shares of the firm's stock in a transaction dated Monday, April 21st. The shares were sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the transaction, the chief executive officer now directly owns 3,063,982 shares of the company's stock, valued at approximately $1,657,583,622.18. This trade represents a 0.33 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Jeri Williams sold 307 shares of the business's stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the sale, the director now directly owns 1,627 shares of the company's stock, valued at $899,275.44. This represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by insiders.
About Axon Enterprise
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Articles
Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
